DOCSLIB.ORG

Identification of the Functional Binding Site for the Convulsant

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Identification of the Functional Binding Site for the Convulsant Molecular Pharmacology Fast Forward. Published on October 27, 2020 as DOI: 10.1124/molpharm.120.000090 This article has not been copyedited and formatted. The final version may differ from this version. Identification of the Functional Binding Site for the Convulsant Tetramethylenedisulfotetramine in the Pore of the α2β3γ2 GABA-A Receptor Brandon Pressly, Ruth D. Lee, Bogdan Barnych, Bruce D. Hammock, Heike Wulff Downloaded from Department of Pharmacology (B.P., R.D.L, H.W.), University of California, Davis, California, USA Department of Entomology and Nematology, and Comprehensive Cancer Center, (B.B., B.D.H.) molpharm.aspetjournals.org University of California, Davis, USA at ASPET Journals on September 24, 2021 1 Molecular Pharmacology Fast Forward. Published on October 27, 2020 as DOI: 10.1124/molpharm.120.000090 This article has not been copyedited and formatted. The final version may differ from this version. Running Title: The Binding Site of TETS Address correspondence to: Heike Wulff, Department of Pharmacology, Genome and Biomedical Sciences Facility, Room 3502, 451 Health Sciences Drive, University of California, Davis, Davis, CA 95616; phone: 530- 754-6136; email: [email protected] Downloaded from Number of Text Pages: 41 Number of Tables: 0 Number of Figures: 8 molpharm.aspetjournals.org Number of References: 43 Number of Words in the Abstract: 217 Number of Words in the Introduction: 725 at ASPET Journals on September 24, 2021 Number of Words in the Discussion: 1,645 Nonstandard abbreviations used: AUC, area under the curve; DMSO, dimethyl sulfoxide; EBOB, 1-(4-ethynylphenyl)-4-n-propyl-2,6,7-trioxabicyclo[2.2.2]octane; ECD, extracellular domain; GABA, gamma-aminobutyric acid; GABAA, GABA receptor type A; HEK, human embryonic kidney; NCA, non-competitive antagonist; pdb, Protein data bank; PAM, positive allosteric modulator; PTX, picrotoxin; REU, Rosetta energy unit; TBPS, tert- butylbicyclophosphorothionate; TETS; tetramethylenedisulfotetramine; TMD, transmembrane domain. 2 Molecular Pharmacology Fast Forward. Published on October 27, 2020 as DOI: 10.1124/molpharm.120.000090 This article has not been copyedited and formatted. The final version may differ from this version. Abstract Tetramethylenedisulfotetramine (TETS) is a so-called “caged” convulsant, that is responsible for thousands of accidental and malicious poisonings. Similar to the widely used GABAA antagonist picrotoxinin, TETS has been proposed to bind to the non-competitive antagonist (NCA) site in the pore of the gamma-aminobutyric acid (GABA) receptor channel. However, the TETS binding site has never been experimentally mapped, and we here set out to gain atomistic level insights Downloaded from into how TETS inhibits the human α2β3γ2 GABAA receptor. Using the Rosetta molecular modeling suite, we generated three homology models of the α2β3γ2 receptor in the open, molpharm.aspetjournals.org desensitized and closed/resting state. Three different ligand docking algorithms (RosettaLigand, Glide and Swissdock) identified two possible TETS binding sites in the channel pore. Using a combination of site-directed mutagenesis, electrophysiology and modeling to probe both sites, we demonstrate that TETS binds at the T6' ring in the closed/resting state model, where it at ASPET Journals on September 24, 2021 shows perfect space-complementarity and is forming hydrogen bonds or making hydrophobic interactions with all five pore-lining threonine residues of the pentameric receptor. Mutating T6' in either the α2 or β3 subunit reduces the IC50 of TETS by ~700-fold in whole-cell patch-clamp experiments. TETS is thus interacting at the NCA site in the pore of the GABAA receptor, at a location that is overlapping but not identical to the picrotoxinin binding site. 3 Molecular Pharmacology Fast Forward. Published on October 27, 2020 as DOI: 10.1124/molpharm.120.000090 This article has not been copyedited and formatted. The final version may differ from this version. Significance Statement Our study identifies the binding site of the highly toxic convulsant TETS (Tetramethylenedisulfotetramine), which is classified as a threat agent by the World Health Organization. Using a combination of homology protein modeling, ligand docking, site-directed mutagenesis and electrophysiology we show that TETS is binding in the pore of the α2β3γ2 Downloaded from GABAA receptor at the so-called T6' ring, where five threonine residues line the permeation pathway of the pentameric receptor channel. This knowledge could help inform the design of a TETS binding therapeutic protein. molpharm.aspetjournals.org at ASPET Journals on September 24, 2021 4 Molecular Pharmacology Fast Forward. Published on October 27, 2020 as DOI: 10.1124/molpharm.120.000090 This article has not been copyedited and formatted. The final version may differ from this version. Introduction GABAA receptors are pentameric ligand-gated chloride channels (Olsen and Sieghart, 2008) that are activated by gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in Downloaded from the mammalian and insect nervous system. GABAA receptors constitute the targets of many widely used drugs as well as for major household and agricultural pesticides. GABAA receptor agonists like barbiturates or positive allosteric modulators (PAMs) as exemplified by the various molpharm.aspetjournals.org typical and atypical benzodiazepines reduce neuronal excitability and are widely used as anesthetics, anxiolytics and anticonvulsants (Krall et al., 2015; Olsen, 2015). In contrast, compounds that inhibit GABAA receptor functions increase neuronal firing. Depending on their species specificity, GABAA antagonist accordingly either constitute useful insecticides like at ASPET Journals on September 24, 2021 fipronil or afoxalaner (Casida and Durkin, 2015), or, if they inhibit mammalian GABAA receptors like picrotoxinin or pentylenetetrazol, induce seizures and, at higher concentrations, death. The extremely toxic tetramethylenedisulfotetramine (TETS) has been known since the early 1940’s and was initially used as an anti-mold agent for furniture. TETS was subsequently investigated both as a rodenticide and as a pesticide (for an extensive review see (Laukova et al., 2019)). However, since human intoxications resulting in death, seizures, and, if victims survived exposure, in neurological deficits and spontaneous recurrent seizures have repeatedly occurred, the World Health Organization therefore banned the use of TETS (Laukova et al., 2019). But, due to its ease of manufacture and its impressive effectiveness in killing rats and mice, TETS continues to be used as a rodenticide in China and presents a real exposure risk to humans and a viable threat agent for inciting a mass casualty incident. Pharmacological experiments performed in the late 1950s demonstrating that sub-lethal doses of TETS could 5 Molecular Pharmacology Fast Forward. Published on October 27, 2020 as DOI: 10.1124/molpharm.120.000090 This article has not been copyedited and formatted. The final version may differ from this version. reverse pentobarbital-induced decreases in blood pressure and respiration in dogs (Haskell and Voss, 1957) suggested that TETS might be targeting GABAA receptors. This was later confirmed in binding assays. TETS, which is far more toxic to mice than to insects (Esser et al., 1991), has affinity for both mammalian GABAA receptors and the insect RDL receptor. While the insect RDL receptor is a homopentamer consisting of 5 identical subunits, mammalian GABAA receptors are typically composed of two α, two β and one γ or subunit assembled as a pentamer around a central chloride conducting pore (Olsen and Sieghart, 2008). In binding Downloaded from 3 assays with rat brain synaptosomes TETS displaces GABAA receptor blockers like [ H]EBOB and [35S]TBPS (Esser et al., 1991; Zhao et al., 2014), most likely by binding to the non- molpharm.aspetjournals.org competitive antagonist site (NCA) in the GABAA receptor pore. However, it was not known whether TETS displayed any subtype selectivity and where exactly it was binding. To address the first question our group recently tested the potency of TETS on the major synaptic and extrasynaptic GABAA receptors associated with convulsant activity using whole-cell patch-clamp at ASPET Journals on September 24, 2021 and reported that TETS is most active on α2β3γ2L and α6β3γ2L GABAA receptors (Pressly et al., 2018). Based on the observation that α2β3γ2 receptors make up 15-20% of the GABAA receptors in the mammalian CNS, we suggested that this receptor combination probably constitutes the most important GABAA receptor target for the seizure inducing activity of TETS (Pressly et al., 2018). The results still left the question of the binding site unanswered. The GABAA field has recently advanced substantially through the publication of numerous new structures (Garcia-Nafria and Tate, 2019). As of now, 19 GABAA receptor structures have been resolved in the closed, open or desensitized state. While the first structure was a homopentamer (Miller and Aricescu, 2014), more physiologically relevant heteropentamers containing α, β and γ subunits have been elucidated using cryo-EM and have started to provide the field molecular insights into both ligand gating and the actions of clinically widely used drugs such as the benzodiazepines (Garcia-Nafria and Tate, 2019; Masiulis et al., 2019). Using three recently published GABAA receptor structures as templates we here 6 Molecular Pharmacology Fast Forward. Published on October
Load more

Recommended publications
  • Picrotoxin-Like Channel Blockers of GABAA Receptors
    COMMENTARY Picrotoxin-like channel blockers of GABAA receptors Richard W. Olsen* Department of Molecular and Medical Pharmacology, Geffen School of Medicine, University of California, Los Angeles, CA 90095-1735 icrotoxin (PTX) is the prototypic vous system. Instead of an acetylcholine antagonist of GABAA receptors (ACh) target, the cage convulsants are (GABARs), the primary media- noncompetitive GABAR antagonists act- tors of inhibitory neurotransmis- ing at the PTX site: they inhibit GABAR Psion (rapid and tonic) in the nervous currents and synapses in mammalian neu- system. Picrotoxinin (Fig. 1A), the active rons and inhibit [3H]dihydropicrotoxinin ingredient in this plant convulsant, struc- binding to GABAR sites in brain mem- turally does not resemble GABA, a sim- branes (7, 9). A potent example, t-butyl ple, small amino acid, but it is a polycylic bicyclophosphorothionate, is a major re- compound with no nitrogen atom. The search tool used to assay GABARs by compound somehow prevents ion flow radio-ligand binding (10). through the chloride channel activated by This drug target appears to be the site GABA in the GABAR, a member of the of action of the experimental convulsant cys-loop, ligand-gated ion channel super- pentylenetetrazol (1, 4) and numerous family. Unlike the competitive GABAR polychlorinated hydrocarbon insecticides, antagonist bicuculline, PTX is clearly a including dieldrin, lindane, and fipronil, noncompetitive antagonist (NCA), acting compounds that have been applied in not at the GABA recognition site but per- huge amounts to the environment with haps within the ion channel. Thus PTX major agricultural economic impact (2). ͞ appears to be an excellent example of al- Some of the other potent toxicants insec- losteric modulation, which is extremely ticides were also radiolabeled and used to important in protein function in general characterize receptor action, allowing and especially for GABAR (1).
    [Show full text]
  • The Anxiomimetic Properties of Pentylenetetrazol in the Rat
    University of Rhode Island DigitalCommons@URI Open Access Dissertations 1980 THE ANXIOMIMETIC PROPERTIES OF PENTYLENETETRAZOL IN THE RAT Gary Terence Shearman University of Rhode Island Follow this and additional works at: https://digitalcommons.uri.edu/oa_diss Recommended Citation Shearman, Gary Terence, "THE ANXIOMIMETIC PROPERTIES OF PENTYLENETETRAZOL IN THE RAT" (1980). Open Access Dissertations. Paper 165. https://digitalcommons.uri.edu/oa_diss/165 This Dissertation is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion in Open Access Dissertations by an authorized administrator of DigitalCommons@URI. For more information, please contact [email protected]. THE ANXIOMIMETIC PROPERTIES OF PENTYLENETETRAZOL IN THE RAT BY GARY TERENCE SHEARMAN A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN PHARMACEUTICAL SCIENCES (PHARMACOLOGY AND TOXICOLOGY) UNIVERSITY OF RHODE ISLAND 19 80 DOCTOR OF PHILOSOPHY DISSERT.A.TION OF GARY TERENCE SHEAffiil.AN Approved: Dissertation Cormnittee \\ Major Professor ~~-L_-_._dd__· _... _______ _ -~ar- Dean of the Graduate School UNIVERSITY OF RHODE ISLAND 1980 ABSTRACT Investigation of the biological basis of anxiety is ham­ pered by the lack of an appropriate animal model for research purposes. There are no known drugs that cause anxiety in laboratory animals. Pentylenetetrazol (PTZ) produces intense anxiety in human volunteers (Rodin, 1958; Rodin and Calhoun, 1970). Therefore, it was the major objective of this disser- tation to test the hypothesis that the discriminative stimu­ lus produced by PTZ in the rat was related to its anxiogenic action in man. It was also an objective to suggest the neuro- chemical basis for the discriminative stimulus property of PTZ through appropriate drug interactions.
    [Show full text]
  • GABA Receptors
    D Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews Review No.7 / 1-2011 GABA receptors Wolfgang Froestl , CNS & Chemistry Expert, AC Immune SA, PSE Building B - EPFL, CH-1015 Lausanne, Phone: +41 21 693 91 43, FAX: +41 21 693 91 20, E-mail: [email protected] GABA Activation of the GABA A receptor leads to an influx of chloride GABA ( -aminobutyric acid; Figure 1) is the most important and ions and to a hyperpolarization of the membrane. 16 subunits with γ most abundant inhibitory neurotransmitter in the mammalian molecular weights between 50 and 65 kD have been identified brain 1,2 , where it was first discovered in 1950 3-5 . It is a small achiral so far, 6 subunits, 3 subunits, 3 subunits, and the , , α β γ δ ε θ molecule with molecular weight of 103 g/mol and high water solu - and subunits 8,9 . π bility. At 25°C one gram of water can dissolve 1.3 grams of GABA. 2 Such a hydrophilic molecule (log P = -2.13, PSA = 63.3 Å ) cannot In the meantime all GABA A receptor binding sites have been eluci - cross the blood brain barrier. It is produced in the brain by decarb- dated in great detail. The GABA site is located at the interface oxylation of L-glutamic acid by the enzyme glutamic acid decarb- between and subunits. Benzodiazepines interact with subunit α β oxylase (GAD, EC 4.1.1.15). It is a neutral amino acid with pK = combinations ( ) ( ) , which is the most abundant combi - 1 α1 2 β2 2 γ2 4.23 and pK = 10.43.
    [Show full text]
  • Treatment Protocol Copyright © 2018 Kostoff Et Al
    Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al PREVENTION AND REVERSAL OF ALZHEIMER'S DISEASE: TREATMENT PROTOCOL by Ronald N. Kostoffa, Alan L. Porterb, Henry. A. Buchtelc (a) Research Affiliate, School of Public Policy, Georgia Institute of Technology, USA (b) Professor Emeritus, School of Public Policy, Georgia Institute of Technology, USA (c) Associate Professor, Department of Psychiatry, University of Michigan, USA KEYWORDS Alzheimer's Disease; Dementia; Text Mining; Literature-Based Discovery; Information Technology; Treatments Prevention and reversal of Alzheimer's disease: treatment protocol Copyright © 2018 Kostoff et al CITATION TO MONOGRAPH Kostoff RN, Porter AL, Buchtel HA. Prevention and reversal of Alzheimer's disease: treatment protocol. Georgia Institute of Technology. 2018. PDF. https://smartech.gatech.edu/handle/1853/59311 COPYRIGHT AND CREATIVE COMMONS LICENSE COPYRIGHT Copyright © 2018 by Ronald N. Kostoff, Alan L. Porter, Henry A. Buchtel Printed in the United States of America; First Printing, 2018 CREATIVE COMMONS LICENSE This work can be copied and redistributed in any medium or format provided that credit is given to the original author. For more details on the CC BY license, see: http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License<http://creativecommons.org/licenses/by/4.0/>. DISCLAIMERS The views in this monograph are solely those of the authors, and do not represent the views of the Georgia Institute of Technology or the University of Michigan. This monograph is not intended as a substitute for the medical advice of physicians. The reader should regularly consult a physician in matters relating to his/her health and particularly with respect to any symptoms that may require diagnosis or medical attention.
    [Show full text]
  • Mixed Antagonistic Effects of the Ginkgolides at Recombinant Human R1 GABAC Receptors
    Neuropharmacology 63 (2012) 1127e1139 Contents lists available at SciVerse ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm Mixed antagonistic effects of the ginkgolides at recombinant human r1 GABAC receptors Shelley H. Huang a, Trevor M. Lewis b, Sarah C.R. Lummis c, Andrew J. Thompson c, Mary Chebib d, Graham A.R. Johnston a, Rujee K. Duke a,* a Discipline of Pharmacology, School of Medical Sciences, Faculty of Medicine, University of Sydney, Australia b School of Medical Sciences, University of New South Wales, Australia c Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom d Faculty of Pharmacy, University of Sydney, Australia article info abstract Article history: The diterpene lactones of Ginkgo biloba, ginkgolides A, B and C are antagonists at a range of Cys-loop Received 11 July 2011 receptors. This study examined the effects of the ginkgolides at recombinant human r1 GABAC recep- Received in revised form tors expressed in Xenopus oocytes using two-electrode voltage clamp. The ginkgolides were moderately 18 June 2012 potent antagonists with IC sinthemM range. At 10 mM, 30 mM and 100 mM, the ginkgolides caused Accepted 24 June 2012 50 rightward shifts of GABA doseeresponse curves and reduced maximal GABA responses, characteristic of noncompetitive antagonists, while the potencies showed a clear dependence on GABA concentration, Keywords: indicating apparent competitive antagonism. This suggests that the ginkgolides exert a mixed-type Ginkgolide Bilobalide antagonism at the r1 GABAC receptors. The ginkgolides did not exhibit any obvious use-dependent Mixed-antagonism inhibition. Fitting of the data to a number of kinetic schemes suggests an allosteric inhibition as Use-dependent a possible mechanism of action of the ginkgolides which accounts for their inhibition of the responses GABAr receptor without channel block or use-dependent inhibition.
    [Show full text]
  • Ligand-Gated Ion Channels' British Journal of Pharmacology, Vol
    Edinburgh Research Explorer The Concise Guide to PHARMACOLOGY 2015/16 Citation for published version: Alexander, SP, Peters, JA, Kelly, E, Marrion, N, Benson, HE, Faccenda, E, Pawson, AJ, Sharman, JL, Southan, C, Davies, JA & CGTP Collaborators 2015, 'The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels' British Journal of Pharmacology, vol. 172, no. 24, pp. 5870-5903. DOI: 10.1111/bph.13350 Digital Object Identifier (DOI): 10.1111/bph.13350 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: British Journal of Pharmacology General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 05. Apr. 2019 S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels. British Journal of Pharmacology (2015) 172, 5870–5903 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Ligand-gated ion channels Stephen PH Alexander1,
    [Show full text]
  • Picrotoxinin and Diazepam Bind to Two Distinct Proteins: Further Evidence That Pentobarbital May Act at the Picrotoxinin Site1
    0270~6474/81/0109-1036$02.00/O The Journal of Neuroscience Copyright 0 Society for Neuroscience Vol. 1, No. 9, pp. 1036-1042 Printed in U.S.A. September 1981 PICROTOXININ AND DIAZEPAM BIND TO TWO DISTINCT PROTEINS: FURTHER EVIDENCE THAT PENTOBARBITAL MAY ACT AT THE PICROTOXININ SITE1 WILLIAM C. DAVIS AND MAHARAJ K. TICKU2 Division of Molecular Pharmacology, Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio. Texas 78284 Abstract a-[3H]Dihydropicrotoxinin (DHP) and [3H]diazepam binding proteins were solubilized from rat brain membranes with 1% Lubrol-Px. Gel filtration of the Lubrol-solubilized fraction revealed that [3H]DHP and [3H]diazepam bind to two distinct peaks with apparent molecular weights of 185,000 and 61,000, respectively. The signal-to-noise ratio of [3H]DHP binding to 185,000-dalton fractions was improved significantly. [3H]DHP bound to the 185,000-dalton fraction with two binding constants. Muscimol and pentobarbital, while enhancing [3H]diazepam binding to membrane and crude Lubrol-solubilized fractions, failed to enhance [3H]diazepam binding to the 61,000-dalton fraction. Pentobarbital inhibited the binding of [3H]DHP to the 185,000-dalton fraction with an IC5” value of 60 + 12 PM. The binding of [3H]DHP also was inhibited by several depressant and convulsant drugs which affect y-aminobutyric acid (GABA)-mediated transmission. These results provide strong evidence that picrotoxinin and diazepam bind to two distinct proteins and that pentobarbital may act at the picrotoxinin-sensitive site of the benzodiazepine . GABA receptor. ionophore complex. The y-aminobutyric acid (GABA) receptor system ap- Olsen, 1978, 1979; Olsen et al., 1979).
    [Show full text]
  • A General Unknown Screening for Drugs and Toxic Compounds in Human Serum
    A General Unknown Screening for Drugs and Toxic Compounds in Human Serum Thesis Submitted to the Faculty of Natural Sciences of the University of Basel, Switzerland for the Fulfilment of the Requirements for a Ph. D. Degree by Stefan Sturm from Biel (BE) Basel, 2005 Accepted by the faculty of natural sciences On proposal of Prof. Dr. Hauser Prof. Dr. Eberle Prof. Dr. Drewe Dr. Scholer Basel, 20. September 2005 Prof. Dr. Wirz Dean Table of Content 1. List of Abbreviations ......................................................................................5 2. Summary.........................................................................................................7 3. Introduction.....................................................................................................9 3.1. GENERAL UNKNOWN SCREENING ............................................................................................. 9 3.2. CHOICE OF SPECIMEN .............................................................................................................. 10 3.3. EXTRACTION TECHNIQUES ...................................................................................................... 10 3.3.1. Liquid-Liquid Extraction .................................................................................................. 10 3.3.2. Solid-Phase Extraction...................................................................................................... 11 3.4. CHROMATOGRAPHY ...............................................................................................................
    [Show full text]
  • Developmental Deltamethrin: Effects on Cognition, Neurotransmitter Systems, Inflammatory Cytokines and Cell Death
    Developmental deltamethrin: Effects on cognition, neurotransmitter systems, inflammatory cytokines and cell death A dissertation submitted to the Graduate School of the University of Cincinnati In partial fulfillment of the requirements for the degree of Doctor of Philosophy In the Neuroscience Graduate Program of the College of Medicine By Emily Pitzer B.S. Westminster College April 2020 Dissertation Committee: Steve Danzer, Ph.D. Mary Beth Genter, Ph.D. Gary Gudelsky, Ph.D. Kimberly Yolton, Ph.D. Charles Vorhees, Ph.D. (Advisor) Michael Williams, Ph.D. (Chair) ABSTRACT Deltamethrin (DLM) is a Type II pyrethroid pesticide and is more widely used with the elimination of organophosphate pesticides. Epidemiological studies have linked elevated levels of pyrethroid metabolites in urine during development with neurological disorders, raising concern for the safety of children exposed to these agents. Few animal studies have explored the effects or mechanisms of DLM-induced deficits in behavior and cognition after developmental exposure. The aim of the present work is to examine the long-term effects of developmental (postnatal day (P) 3-20) DLM exposure in Sprague-Dawley rats on behavior, cognition, and cellular outcomes. First, the developmental effects of early DLM exposure on allocentric and egocentric learning and memory, locomotor activity, startle, conditioned freezing, and anxiety-like behaviors were assessed. The developmental effects of DLM on long-term potentiation (LTP) at P25-35, on adult dopamine (DA) release, monoamine levels, and mRNA levels of receptors/transporters/channels were then determined. In follow-up experiments, adult LTP, hippocampal glutamate release, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining for cell death, as well as DA and glutamate receptors, proinflammatory cytokines, and caspase-3 for protein expression were assessed.
    [Show full text]
  • Tutu Toxicity: Three Case Reports of Coriaria Arborea Ingestion, Review
    THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association Tutu toxicity: three case reports of Coriaria arborea ingestion, review of literature and recommendations for management Sally F Belcher, Tom R Morton Abstract We describe three cases of tutu berry (Coriaria arborea ) ingestion resulting in tonic- clonic seizures in two individuals and mild symptoms in the third. Tutu poisoning in humans appears to be a rare occurrence; the last reported case in the medical literature being over 40 years ago. We review the literature on tutu poisoning and recommend extending the period of observation for poisoned individuals from 8 hours to 12 hours or longer. We also recommend that prophylactic benzodiazepine use should be considered in those with mild to moderate symptoms of poisoning. Background There are about 30 species of Coriariaceae found around the world including southern Europe, eastern Asia, south and central America, and New Zealand.1 The six species native to New Zealand and the Chatham islands (Coriaria angustissim, C. arborea, C. lurida, C. plumosa, C. pteridoides and C. sarmentosa ) are all known by the name tutu 1 and are mostly deciduous shrubs found in grassland. There is variety in appearance and distribution as seen with Coriaria arborea, or “tree tutu”, which may become an evergreen tree growing to 6 metres in height and being found in coastal and montaine forest.2 The primary toxin, tutin , was discovered in 1870 3 and is found in all varieties of tutu 1,2 . It is a picrotoxin-like toxin which acts as an antagonist at amino acid receptors within the CNS, especially the medullary, cortical, respiratory, vasomotor, and autonomic centers 4.
    [Show full text]
  • Cicuta Douglasii) Tubers
    Toxicon 108 (2015) 11e14 Contents lists available at ScienceDirect Toxicon journal homepage: www.elsevier.com/locate/toxicon Short communication The non-competitive blockade of GABAA receptors by an aqueous extract of water hemlock (Cicuta douglasii) tubers * Benedict T. Green a, , Camila Goulart b, 1, Kevin D. Welch a, James A. Pfister a, Isabelle McCollum a, Dale R. Gardner a a Poisonous Plant Research Laboratory, Agricultural Research Service, United States Department of Agriculture, Logan, UT, USA b Graduate Program in Animal Science, Universidade Federal de Goias, Goiania,^ Goias, Brazil article info abstract Article history: Water hemlocks (Cicuta spp.) are acutely toxic members of the Umbellierae family; the toxicity is due to Received 22 July 2015 the presence of C17-polyacetylenes such as cicutoxin. There is only limited evidence of noncompetitive Received in revised form antagonism by C17-polyacetylenes at GABAA receptors. In this work with WSS-1 cells, we documented 9 September 2015 the noncompetitive blockade of GABA receptors by an aqueous extract of water hemlock (Cicuta dou- Accepted 14 September 2015 A glasii) and modulated the actions of the extract with a pretreatment of 10 mM midazolam. Available online 28 September 2015 Published by Elsevier Ltd. Keywords: Water hemlock Cicutoxin C17-polyacetylenes Benzodiazepines Barbiturates Midazolam Water hemlocks (Cicuta spp.) are acutely toxic members of the antagonists of the GABAA receptor by binding to the picrotoxin Umbellierae, or carrot family, that grow in wet habitats such as binding site within the chloride channel to block ion flow through streambeds or marshlands, and have been considered one of the the channel (Ratra et al., 2001; Chen et al., 2006; 2011; Olsen, most toxic plants of North America for many years (Kingsbury, 2006).
    [Show full text]
  • 解 説 GABA Synapse
    日 本 農 薬 学 会 誌10, 555-567 (1985) 解 説 GABA支 配 の 神 経 シ ナ ッ プ ス -殺 虫 剤 の タ ー ゲ ッ ト?- 田 中 啓 司 三共株式会社農薬研究所 (昭和60年5月20日 受理) GABA Synapse: A Target Site of Insecticides? Keiji TANAKA Agricultural Chemicals Research Laboratories, Sanhyo Co., Ltd., Yasu-cho, Yasu-gun, Shiga 520-23, Japan やavermectin8)の 出現 で あ る. は じ め に 節 足 動 物 に お け るGABAの 作 用 1950年 に γ-aminobutyric acid (GABA) が マ ウス脳 か ら単 離 同 定1,2)さ れ てか ら, そ の 神 経 伝 達 物 質 と し て Usherwoodら9, 10)は, 昆 虫 の抑 制 性 の神 経 一筋 接 合 部 の 歴 史 が 始 ま る. しか し, 長 い間, この ア ミノ酸 の脳 内 位 でGABAが 当 時 構 造 未 知 で あ った 抑 制 性 の神 経 伝 達 で の 作 用 は 不 明 の まま で, た ん にご代 謝 産 物 で あ ろ うと考 物 質 と 同様 にご作 用 す る こ とを 見 い だ した. GABAは 抑 制 え られ た 時 が あ った ほ どで あ る3). そ の 薬理 作用 が 発 見 性 神 経 が 入 りこ んで い る 筋 線 維 膜 の"input"コ ン ダ ク され た の は 哺 乳動 物 で は な く, 甲殻 類 を用 い て の研 究 で, タ ンス を 増 加 させ る.
    [Show full text]